Skip to main content
Equibles

STATE STREET CORP

Position in CGON — CG Oncology, Inc.

CIK 93751 BOSTON, MA
Back to CGON Full portfolio

Position in CGON

as of Jun 30, 2026 · filed Sep 22, 2026
Position Value
$244,240,769
+$65,088,155 QoQ
Shares Held
3,437,590
+29.9% QoQ
Ownership
3.88%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 12% Shared 0% None 88%

Common Shares in CGON Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,949,192,558 across 423 Biotechnology names. CGON ranks #37 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in CGON

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $244,240,769 3,437,590
2026-03-31 $179,152,614 2,647,054
2025-12-31 $124,422,776 2,996,695
2025-09-30 $82,439,746 2,046,667
2025-06-30 $56,309,578 2,165,753
2025-03-31 $48,183,805 1,967,489
2024-12-31 $55,168,389 1,923,584
2024-09-30 $64,165,637 1,700,653
2024-06-30 $31,031,131 982,931
2024-03-31 $15,401,480 350,831